BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33989642)

  • 1. Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome.
    Graillon T; Boissonneau S; Appay R; Boucekine M; Peyrière H; Meyer M; Farah K; Albarel F; Morange I; Castinetti F; Brue T; Fuentes S; Figarella-Branger D; Cuny T; Dufour H
    Neurochirurgie; 2021 Nov; 67(6):556-563. PubMed ID: 33989642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.
    Devalckeneer A; Aboukais R; Bourgeois P; De Witte O; Racape J; Caron S; Perbet R; Maurage CA; Lejeune JP
    Clin Neurol Neurosurg; 2021 Nov; 210():106959. PubMed ID: 34592677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.
    Malaize H; Samoyeau T; Zanello M; Roux A; Benzakoun J; Peeters S; Zah-Bi G; Edjlali M; Tauziede-Espariat A; Dezamis E; Parraga E; Chrétien F; Varlet P; Plu-Bureau G; Oppenheim C; Pallud J
    J Neurooncol; 2021 Apr; 152(2):279-288. PubMed ID: 33449307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningioma under progestin treatment : what attitude to adopt ?].
    Cornu E; Pintiaux A; Reuter G; Kridelka F; Pétrossians P; Potorac I
    Rev Med Liege; 2023 Oct; 78(10):550-557. PubMed ID: 37830319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation.
    Florea SM; Passeri T; Abbritti R; Bernat AL; Fontanel S; Yoldjian I; Funck-Brentano T; Weill A; Mandonnet E; Froelich S
    J Neurosurg; 2023 Oct; 139(4):944-952. PubMed ID: 36883659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series.
    Devalckeneer A; Aboukais R; Faisant M; Bourgeois P; Quentin VM; Maurage CA; Escande F; Lejeune JP
    Neurosurg Rev; 2022 Apr; 45(2):1691-1699. PubMed ID: 34850321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
    Passeri T; Giammattei L; Le Van T; Abbritti R; Perrier A; Wong J; Bourneix C; Polivka M; Adle-Biassette H; Bernat AL; Masliah-Planchon J; Mandonnet E; Froelich S
    Acta Neurochir (Wien); 2022 Jan; 164(1):255-263. PubMed ID: 34613529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningioma in patients exposed to progestin drugs: results from a real-life screening program.
    Samoyeau T; Provost C; Roux A; Legrand L; Dezamis E; Plu-Bureau G; Pallud J; Oppenheim C; Benzakoun J
    J Neurooncol; 2022 Oct; 160(1):127-136. PubMed ID: 36066786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproterone acetate and meningioma: a nationwide-wide population based study.
    Champeaux-Depond C; Weller J; Froelich S; Sartor A
    J Neurooncol; 2021 Jan; 151(2):331-338. PubMed ID: 33394263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and Progesterone Therapy and Meningiomas.
    Hage M; Plesa O; Lemaire I; Raffin Sanson ML
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas.
    Apra C; Roblot P; Alkhayri A; Le Guérinel C; Polivka M; Chauvet D
    J Neurooncol; 2020 Aug; 149(1):95-101. PubMed ID: 32705456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First case of cyproterone acetate induced multiple meningiomas in identical female twins: A case report.
    Batchinsky-Parrou V; Barraud S; Kleiber JC; Litre F
    Neurochirurgie; 2022 Apr; 68(3):323-326. PubMed ID: 33989640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of intracranial meningioma with three potent progestogens: A population-based case-control study.
    Hoisnard L; Laanani M; Passeri T; Duranteau L; Coste J; Zureik M; Froelich S; Weill A
    Eur J Neurol; 2022 Sep; 29(9):2801-2809. PubMed ID: 35621369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.
    Weill A; Nguyen P; Labidi M; Cadier B; Passeri T; Duranteau L; Bernat AL; Yoldjian I; Fontanel S; Froelich S; Coste J
    BMJ; 2021 Feb; 372():n37. PubMed ID: 33536184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra cranial meningiomas and long term use of cyproterone acetate with a conventional dose in women. A report of two cases of tumor decrease after treatment withdrawal].
    Botella C; Coll G; Lemaire JJ; Irthum B
    Neurochirurgie; 2015 Oct; 61(5):339-42. PubMed ID: 26249273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
    Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
    Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy.
    AbiJaoude S; Marijon P; Roblot P; Tran S; Cornu P; Kalamarides M; Peyre M
    Acta Neurochir (Wien); 2021 Jun; 163(6):1705-1710. PubMed ID: 33649877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological evolution of progestogen-induced meningioma: A monocentric retrospective study.
    Ahmed-Khalifa T; Gillet R; Blonski M; Rech F; Fresse A; Gillet P; Taillandier L; Petitpain N
    Fundam Clin Pharmacol; 2023 Aug; 37(4):868-878. PubMed ID: 36692232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report.
    Champagne PO; Passeri T; Froelich S
    Acta Neurochir (Wien); 2019 Mar; 161(3):589-592. PubMed ID: 30666456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients.
    Bernat AL; Oyama K; Hamdi S; Mandonnet E; Vexiau D; Pocard M; George B; Froelich S
    Acta Neurochir (Wien); 2015 Oct; 157(10):1741-6. PubMed ID: 26264069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.